Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.
Trial details
- Registry ID
- NCT01703754
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as Pali
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.NCT01703754 | Alaunos Therapeutics | Phase 2 | Terminated | 2014-08-07Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |